1. ScholarBank@NUS

H. Phillip Koeffler

rp05987

Collaboration Map View Statistics Email Alert RSS Feed

Profile

Full Name
H. Phillip Koeffler
Variants
Phillip Koeffler, H.
Koeffler Philip H.
Koeffler H.P.
Koeffler, H.P.
 
Main Affiliation
 
Faculty
 
Email
mdchpk@nus.edu.sg
 
Other emails
 

Publications

Refined By:
Subject:  controlled study

Results 1-11 of 11 (Search time: 0.016 seconds).

Issue DateTitleAuthor(s)
12005CCAAT/enhancer binding protein α (C/EBPα) and C/EBPα myeloid oncoproteins induce Bcl-2 via interaction of their basic regions with nuclear factor-κB p50Paz-Priel, I; Cai, D.H; Wang, D; Kowalski, J; Blackford, A; Liu, H; Heckman, C.A; Gombart, A.F; Koeffler, H.P ; Boxer, L.P; Friedman, A.D
22015FoxM1 transactivates PTTG1 and promotes colorectal cancer cell migration and invasionZheng, Y; Guo, J; Zhou, J; Lu, J; Chen, Q; Zhang, C; Qing, C; Koeffler, H.P ; Tong, Y
32015Genomic landscape of liposarcomaKanojia, D ; Nagata, Y; Garg, M ; Lee, D.H ; Sato, A; Yoshida, K; Sato, Y; Sanada, M; Mayakonda, A ; Bartenhagen, C; Klein, H.-U; Doan, N.B; Said, J.W; Mohith, S; Gunasekar, S; Shiraishi, Y; Chiba, K; Tanaka, H; Miyano, S; Myklebost, O; Yang, H ; Dugas, M; Meza-Zepeda, L.A; Silberman, A.W; Forscher, C; Tyner, J.W; Ogawa, S; Phillip Koeffler, H 
42017Identification of a novel SYK/c-MYC/MALAT1 signaling pathway and its potential therapeutic value in Ewing sarcomaSun, H; Lin, D.-C ; Cao, Q; Pang, B ; Gae, D.D; Lee, V.K.M ; Lim, H.J; Doan, N; Said, J.W; Gery, S; Chow, M; Mayakonda, A ; Forscher, C; Tyner, J.W; Koeffler, H.P 
52016Inhibition of IRE1?-driven pro-survival pathways is a promising therapeutic application in acute myeloid leukemiaSun, H; Lin, D.-C ; Guo, X; Masouleh, B.K; Gery, S; Cao, Q; Alkan, S; Ikezoe, T; Akiba, C; Paquette, R; Chien, W ; Müller-Tidow, C; Jing, Y; Agelopoulos, K; Müschen, M; Koeffler, H.P 
62008Kill502, a novel multitargeted receptor tyrosine kinase inhibitor, induces growth arrest and apoptosis of human leukemia cells in vitro and in vivoNishioka, C; Ikezoe, T; Yang, J; Miwa, A; Tasaka, T; Kuwayama, Y; Togitani, K; Koeffler, H.P ; Yokoyama, A
72017Kinase profiling of liposarcomas using RNAi and drug screening assays identified druggable targetsKanojia, D ; Garg, M ; Martinez, J; Anand, M.T ; Luty, S.B; Doan, N.B; Said, J.W; Forscher, C; Tyner, J.W; Koeffler, H.P 
82016Low expression of DYRK2 (dual specificity tyrosine phosphorylation regulated kinase 2) correlates with poor prognosis in colorectal cancerYan H.; Hu K.; Wu W.; Li Y.; Tian H.; Chu Z.; Koeffler H.P. ; Yin D.
92017Molecular mechanism and therapeutic implications of selinexor (KPT-330) in liposarcomaGarg, M ; Kanojia, D ; Mayakonda, A ; Said, J.W; Doan, N.B; Chien, W ; Ganesan, T.S; Chuang, L.S.H ; Venkatachalam, N; Baloglu, E; Shacham, S; Kauffman, M; Koeffler, H.P 
102014Oncogenic function and prognostic significance of protein tyrosine phosphatase PRL-1 in hepatocellular carcinomaJin, S; Wang, K; Xu, K; Xu, J; Sun, J; Chu, Z; Lin, D ; Koeffler, P.H ; Wang, J; Yin, D
112005Transcription profiling of C/EBP targets identifies Per2 as a gene implicated in myeloid leukemiaGery, S; Gombart, A.F.; Yi, W.S.; Koeffler, C.; Hofmann, W.-K.; Koeffler, H.P.